Van Houte Hans Insider Trading Activity
Van Houte Hans has been net-selling over the last 12 months with 0 purchases and 9 sales across 1 company.
NRIX is the most-traded position with 9 trades. The largest single transaction was a sale of NRIX for $223K on May 5, 2026.
Performance Scorecard
Forward stock performance after each transaction by Van Houte Hans. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +0.2% | 67% | 9 |
| 90 days | — | -14.6% | 33% | 6 |
| 120 days | — | -26.0% | 0% | 6 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersNRIX · Nurix Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Van Houte Hans bought and sold NRIX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 5, 2026 | NRIX | Sell | 13,473 | $16.58 | $223K | −26.1% | CFO | |
May 5, 2026 | NRIX | Sell | 582 | $17.18 | $10K | −1.5% | CFO | |
Apr 30, 2026 | NRIX | Sell | 2,388 | $16.65 | $40K | −4.4% | CFO | |
Jan 30, 2026 | NRIX | Sell | 3,588 | $16.58 | $59K | −7.3% | CFO | |
Jan 30, 2026 | NRIX | Sell | 73 | $17.37 | $1K | −0.2% | CFO | |
Nov 3, 2025 | NRIX | Sell | 6,284 | $12.56 | $79K | −14.3% | CFO | |
Oct 30, 2025 | NRIX | Sell | 3,130 | $12.80 | $40K | −6.7% | CFO | |
Aug 1, 2025 | NRIX | Sell | 5,402 | $11.03 | $60K | −13.2% | CFO | |
Jul 30, 2025 | NRIX | Sell | 4,304 | $12.01 | $52K | −9.5% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 9 | $564K |
Other insiders at Nurix Therapeutics, Inc.
2 other tracked filers at NRIX.